Entries by visicort_admin

VISICORT publication in the Official Journal of the Transplantation Society

Congratulations to the team! VISICORT PIs and researchers spanning the consortium have recently released a new paper in the Official Journal of the Transplantation Society. The paper entitled: “High-Risk Corneal Transplantation, Recent Developments and Future Possibilities” was released 22 August 2019. Authors are W. John Armitage, PhD; Christine Goodchild, MD; Matthew D. Griffin, DMed; David […]

VISICORT PI Ritter, NUI Galway joins Therapeutics Delivery COST Action

Prof. Thomas Ritter of NUI Galway has joined “DARTER”- a COST Action CA 17103- Delivery of Antisense RNA Therapeutics. Here, Thomas aims to broaden his research network and to forge new partnerships to explore novel, RNA-based therapies for the treatment of ocular defects and the modulation of corneal transplant rejection. DARTER has three research objectives- […]

VISICORT PIs present at Societas Ophthalmologica Europæa

On June 16, 2019, Prof. Jesper Hjortdal, of the Aarhus University Hospital gave a presentation at the SOE (Societas Ophthalmologica Europæa, or European Society of Ophthalmology) on “Adverse immune signatures after corneal transplantation” based on the preliminary findings in the VISICORT study. This year the SOE held its bi-annual meeting in Nice, France. The symposium […]

Interview 2: Proteomics Specialist Lisa Imrie, U of Edinburgh offers a research career snapshot

In the 5 years since its launch, VISICORT has gathered a unique collection of biological samples from corneal transplant recipients across 5 European countries. We are especially motivated to ensure that the generosity of these patients has a legacy of new research that continues to grow beyond the life-time of the project itself. Lisa’s exciting […]

Interview: Lisa Imrie, U of Edinburgh uses the VISICORT Biobank

Lisa Imrie is a Proteomics Specialist at the University of Edinburgh and a graduate of Edinburgh Napier University with a degree in microbiology and biotechnology. She has recently started her PhD studies taking a unique perspective in the analysis of biosamples from the VISICORT Foundation Biobank. Danielle Nicholson, Pintail Limited caught up with Lisa Imrie […]

New VISICORT publication from NUI Galway team

“TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung” was published online in the FASEB Journal on May 20, 2019. The authors of the study from NUI Galway are Nick Murphy, Oliver Treacy, Kevin Lynch, Maurice Morcos, Paul Lohan, Linda Howard, Gerry Fahy, Matthew D. […]

Prof Ritter presents at ARVO 2019, Canada

VISICORT PI Prof Thomas Ritter of the NUI Galway presented at the recent Association for Research in Vision and Ophthalmology (ARVO) meeting in Vancouver, British Colombia, Canada. Thomas’ abstract, “Subconjunctival injection of low-dose mesenchymal stem cells promotes corneal allograft survival in a mouse cornea transplantation model” was presented Wednesday, May 1st during the “Corneal Neuropathy […]

VISICORT presentation in Berlin aims to recruit potential patients to the clinical trial

VISICORT PI Uwe Pleyer at Charité Universitätsmedizin Berlin organized a seminar entitled “Autologe Stammzelltherapie zur Prophylaxe der Immunreaktion bei Risikokeratoplastik”. The Anterior Segment Symposium on April 27th, 2019 in Berlin included a presentation on the VISICORT project with the aim to recruit potential patients for the Phase 1 trial. Pictured above Prof. Dr Rieck and […]